Compositions and methods for drug delivery

Details for Australian Patent Application No. 2010249008 (hide)

Owner Baxter Healthcare S.A. Baxter International Inc.

Inventors Rabinow, Barrett; Bairstow, Shawn F.; Chaubal, Mahesh V.; Lee, Sarah; Werling, Jane

Agent Peter Maxwell & Associates

Pub. Number AU-A-2010249008

PCT Pub. Number WO2010/132664

Priority 12/467,230 15.05.09 US

Filing date 13 May 2010

Wipo publication date 18 November 2010

International Classifications

A61K 9/14 (2006.01) Medicinal preparations characterised by special physical form - Particulate form, e.g. powders

A61K 31/337 (2006.01) - having four-membered rings, e.g. taxol

A61K 47/34 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

1 December 2011 PCT application entered the National Phase

  PCT publication WO2010/132664 Priority application(s): WO2010/132664

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010249015-Treatment of MCI and Alzheimer's disease

2010249003-Anti-human CD52 immunoglobulins